Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-12-12 00:00:00 ET · period of report 2023-12-08 · accession 0001127602-23-029444 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-12 | 2023-12-12 | DNA | Canton Barry | 10% | G - Gift | $0.00 | -200.0K | 12.45M | -2% | $0 |
| D | 2023-12-12 | 2023-12-08 | DNA | Canton Barry | 10% | C - Cnv Deriv | — | +200.0K | 12.65M | +2% | — |
| DI | 2023-12-12 | 2023-12-08 | DNA | Canton Barry | 10% | C - Cnv Deriv | — | -200.0K | 69.99M | -0.3% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-12 | G | D | 200,000 | $0.00 | 12,449,844 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-12-08 | C | A | 200,000 | — | 12,649,844 | D | — | — | (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 3 | Derivative | Class B Common Stock | 2023-12-08 | C | D | 200,000 | — | 69,989,783 | I By Bartholomew Canton Living Trust | — · — to — | 200,000 Class A Common Stock | (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |